RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice

被引：5
作者：
Pitt, Bertram [1 ]
机构：
[1] Univ Michigan, Sch Med, Div Cardiol, Ann Arbor, MI 48104 USA
来源：
HEART | 2009年 / 95卷 / 15期
关键词：
CONVERTING-ENZYME-INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; ANGIOTENSIN-RECEPTOR BLOCKER; CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; HIGH-RISK PATIENTS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; DOUBLE-BLIND; ESSENTIAL-HYPERTENSION;
D O I：
10.1136/hrt.2009.167080
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1205 / 1208
页数：4
相关论文
共 41 条
  • [1] Agodoa L, 2007, J HYPERTENS, V25, P951
  • [2] Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists - A comparison of lismopril and losartan
    Akinboboye, OO
    Chou, RL
    Bergmann, SR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) : 703 - 709
  • [3] Braunwald E, 2004, NEW ENGL J MED, V351, P2058
  • [4] Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or β-blockade in patients with essential hypertension
    Buus, NH
    Bottcher, M
    Jorgensen, CG
    Christensen, KL
    Thygesen, K
    Nielsen, TT
    Mulvany, MJ
    [J]. HYPERTENSION, 2004, 44 (04) : 465 - 470
  • [5] Hyperaldosteronism among with resistant black and white subjects hypertension
    Calhoun, DA
    Nishizaka, MK
    Zaman, MA
    Thakkar, RB
    Weissmann, P
    [J]. HYPERTENSION, 2002, 40 (06) : 892 - 896
  • [6] Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: No answer yet
    Cashin-Hemphill, L
    Holmvang, G
    Chan, RC
    Pitt, B
    Dinsmore, RE
    Lees, RS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (01) : 43 - 47
  • [7] Effect of spironolactone on blood pressure in subjects with resistant hypertension
    Chapman, Neil
    Dobson, Joanna
    Wilson, Sarah
    Dahlof, Bjorn
    Sever, Peter S.
    Wedel, Hans
    Poulter, Neil R.
    [J]. HYPERTENSION, 2007, 49 (04) : 839 - 845
  • [8] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675
  • [9] Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure
    Cruden, NLM
    Witherow, FN
    Webb, DJ
    Fox, KAA
    Newby, DE
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (06) : 1043 - 1048
  • [10] Aldosterone synthase inhibitor ameliorates angiotensin II - Induced organ damage
    Fiebeler, A
    Nussberger, JR
    Shagdarsuren, E
    Rong, S
    Hilfenhaus, G
    Al-Saadi, N
    Dechend, R
    Wellner, M
    Meiners, S
    Maser-Gluth, C
    Jeng, AY
    Webb, RL
    Luft, FC
    Muller, DN
    [J]. CIRCULATION, 2005, 111 (23) : 3087 - 3094
12345